Reformulating the Future of Small Molecules - Scorecard - MDSpire

Reformulating the Future of Small Molecules

A special collection of recent stories exploring oral dose innovation, API stability, nitrosamine testing, and the evolving science of small molecule medicines

  • June 30, 2026

  • 1 min

Share

Clinical Scorecard: Reformulating the Future of Small Molecules

At a Glance

CategoryDetail
ConditionSmall Molecule Development
Key MechanismsAPI stability, nitrosamine testing, formulation innovation
Target PopulationPharmaceutical developers and manufacturers
Care SettingPharmaceutical development and manufacturing

Key Highlights

  • Focus on API stability and predictive tools for degradation pathways
  • Evolution of softgel formulations using glycerin and sorbitol
  • Challenges in managing formulation changes in Europe
  • Discussion on nitrosamine testing and ultra-trace detection
  • Insights on API-excipient interactions and risk assessment

Guideline-Based Recommendations

Diagnosis

    Management

      Monitoring & Follow-up

        Risks

          Patient & Prescribing Data

          Clinical Best Practices

            Related Resources & Content

              Original Source(s)

              Reformulating the Future of Small Molecules

              • June 30, 2026

              Related Content

              Breast Cancer Incidence in Asian American, Native Hawaiian, and Pacific Islander Populations, 2000-2022

              Effects of a clinical metagenomics intervention on clinical outcomes, healthcare costs, and health-related quality of life in patients with sepsis or septic shock: results of the randomized-controlled DigiSep trial

              A retrospective cohort study on the impact of gonadotropin dose on embryo quality and pregnancy outcome: identification of optimal dose range